Abstract

Molecules on the cell membrane dictate how cells interact with their environment and other cells, and serve as the target for tumor immunotherapy. Enzyme-catalyzed proximity labeling has become a pivotal tool for studying intercellular communication and functionalizing cell membranes. To enable more precise and efficient enzymatic labeling for cell membrane engineering, further investigation of novel labeling strategies is crucial. In this study, we developed a precise chemoenzymatic labeling strategy using SrtA-SpA C , mediated by antibodies (Ab-SS), as a general method for detecting cell-cell interactions (CCI) and constructing antibody-cell conjugates (ACCs) for tumor immunotherapy. Firstly, we successfully employed the Ab-SS strategy to label specific cell populations within complex cellular environments. Furthermore, this method can be precisely extended to label cell groups that interact with the target cells. Employing the Ab-SS system, we report a potent ACCs platform as an alternative to chimeric antigen receptor (CAR) technology. This platform precisely equips immune cells with tumor-targeting antibodies to direct their recognition and attack against cancer cells. Collectively, given its flexibility and robust functionality, the Ab-SS enzymatic labeling system provides a generalized strategy for facilitating research on cellular function and advancing targeted immune cell therapies through proximity labeling.